Relmada Therapeutics RLMD
$ 2.82
2.55%
Quarterly report 2024-Q3
added 11-07-2024
Relmada Therapeutics EV/EBITDA Ratio 2011-2024 | RLMD
Annual EV/EBITDA Ratio Relmada Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-2.91 | -8.34 | -3.53 | -2.37 | -1.17 | -0.869 | -2.92 | -0.402 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-0.402 | -8.34 | -2.81 |